These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28946906)

  • 1. Methadone maintenance-lessons from two systems in China.
    Lee SS; Newman R
    Harm Reduct J; 2017 Sep; 14(1):66. PubMed ID: 28946906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
    Salsitz E; Wiegand T
    J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.
    McNeil R; Kerr T; Anderson S; Maher L; Keewatin C; Milloy MJ; Wood E; Small W
    Soc Sci Med; 2015 May; 133():168-76. PubMed ID: 25875323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Chinese police in methadone maintenance therapy: a literature review.
    Meng J; Burris S
    Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
    Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
    Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.
    Gauthier G; Eibl JK; Marsh DC
    Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an implementation of methadone maintenance treatment in China.
    Marienfeld C; Liu P; Wang X; Schottenfeld R; Zhou W; Chawarski MC
    Drug Alcohol Depend; 2015 Dec; 157():60-7. PubMed ID: 26601934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Service providers' adherence to methadone maintenance treatment protocol in China.
    Lin C; Lan CW; Li L; Rou K
    Int J Drug Policy; 2018 Jun; 56():1-5. PubMed ID: 29529449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand.
    Khampang R; Assanangkornchai S; Teerawattananon Y
    Drug Alcohol Rev; 2015 Nov; 34(6):645-53. PubMed ID: 25867927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
    Zhou K; Zhuang G
    Addict Behav; 2014 Jan; 39(1):22-9. PubMed ID: 24090627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services.
    Li J; Wang C; McGoogan JM; Rou K; Bulterys M; Wu Z
    Bull World Health Organ; 2013 Feb; 91(2):130-5. PubMed ID: 23554525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-assisted treatment with methadone: assessing the evidence.
    Fullerton CA; Kim M; Thomas CP; Lyman DR; Montejano LB; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):146-57. PubMed ID: 24248468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic costs of jail-based methadone maintenance treatment.
    Horn BP; Li X; Mamun S; McCrady B; French MT
    Am J Drug Alcohol Abuse; 2018; 44(6):611-618. PubMed ID: 30024783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone maintenance therapy outcomes in Iran.
    Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who uses methadone services in China? Monitoring the world's largest methadone programme.
    Sullivan SG; Wu Z; Rou K; Pang L; Luo W; Wang C; Cao X; Yin W; Liu E; Mi G;
    Addiction; 2015 Jan; 110 Suppl 1():29-39. PubMed ID: 25533862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study.
    Zou X; Xu Y; Chen W; Xia Y; Liu Y; Gong C; Ling L
    Subst Abuse Treat Prev Policy; 2018 Jan; 13(1):1. PubMed ID: 29321039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.